Puretech Health plc (PRTC) Ordinary 1p
5.60p
(4.40%)
- Add to watchlist
- Create an alert
- This stock can be held in a
5.60p
(4.40%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
5.60p
(4.40%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
128.00p
133.60p
178.00p
£320.47 million
127.20p
127.95p
100.40p
n/a
2.40p (1.85%) Previous:
2.40p
285,429
n/a
7,500
Performance
| 1 week 1W | 5.78% | 1 year 1Y | 24.64% |
|---|---|---|---|
| 1 month 1M | 2.3% | 2 years 2Y | 36.27% |
| 3 months 3M | 3.25% | 3 years 3Y | 46.1% |
| 6 months 6M | 11.91% | 5 years 5Y | 52.71% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
PureTech launches respiratory development vehicle Celea Therapeutics
12 August 2025 12:04
-
PureTech Health CEO Bharatt Chowrira steps down
16 July 2025 07:44
-
PureTech financials improve in a year of clinical, regulatory milestones
30 April 2025 10:35
-
PRTC Launches Celea to Advance Ph3-Ready IPF Drug
12 August 2025 12:00
-
Holding(s) in Company
5 August 2025 17:30
-
Total Voting Rights
1 August 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.